Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 860

1.

The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.

Franzmeier N, Rubinski A, Neitzel J, Ewers M; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Nat Commun. 2019 Apr 16;10(1):1766. doi: 10.1038/s41467-019-09564-5.

PMID:
30992433
2.

Regional cortical thickness and neuroticism across the lifespan.

Sweeney M, Tsapanou A, Stern Y.

Psychiatry Res Neuroimaging. 2019 Apr 30;286:39-44. doi: 10.1016/j.pscychresns.2019.03.005. Epub 2019 Mar 7.

PMID:
30878715
3.

A blood-based signature of cerebrospinal fluid Aβ1-42 status.

Goudey B, Fung BJ, Schieber C, Faux NG; Alzheimer’s Disease Metabolomics Consortium; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Mar 11;9(1):4163. doi: 10.1038/s41598-018-37149-7.

4.

Mechanisms underlying resilience in ageing.

Stern Y, Chételat G, Habeck C, Arenaza-Urquijo EM, Vemuri P, Estanga A, Bartrés-Faz D, Cantillon M, Clouston SAP, Elman JA, Gold BT, Jones R, Kempermann G, Lim YY, van Loenhoud A, Martínez-Lage P, Morbelli S, Okonkwo O, Ossenkoppele R, Pettigrew C, Rosen AC, Scarmeas N, Soldan A, Udeh-Momoh C, Valenzuela M, Vuoksimaa E.

Nat Rev Neurosci. 2019 Apr;20(4):246. doi: 10.1038/s41583-019-0138-0. No abstract available.

PMID:
30814677
6.

Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics.

Varatharajah Y, Ramanan VK, Iyer R, Vemuri P; Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Feb 19;9(1):2235. doi: 10.1038/s41598-019-38793-3.

7.

Predicting Alzheimer's disease progression using multi-modal deep learning approach.

Lee G, Nho K, Kang B, Sohn KA, Kim D; for Alzheimer’s Disease Neuroimaging Initiative.

Sci Rep. 2019 Feb 13;9(1):1952. doi: 10.1038/s41598-018-37769-z.

8.

Effect of aerobic exercise on cognition in younger adults: A randomized clinical trial.

Stern Y, MacKay-Brandt A, Lee S, McKinley P, McIntyre K, Razlighi Q, Agarunov E, Bartels M, Sloan RP.

Neurology. 2019 Feb 26;92(9):e905-e916. doi: 10.1212/WNL.0000000000007003. Epub 2019 Jan 30.

PMID:
30700591
9.

Type 2 diabetes mellitus, brain atrophy, and cognitive decline.

Moran C, Beare R, Wang W, Callisaya M, Srikanth V; Alzheimer's Disease Neuroimaging Initiative (ADNI).

Neurology. 2019 Feb 19;92(8):e823-e830. doi: 10.1212/WNL.0000000000006955. Epub 2019 Jan 23.

PMID:
30674592
10.

Physical exercise and activity may be important in reducing dementia risk at any age.

Mortimer JA, Stern Y.

Neurology. 2019 Feb 19;92(8):362-363. doi: 10.1212/WNL.0000000000006935. Epub 2019 Jan 16. No abstract available.

PMID:
30651385
11.

Metacognition strengthens the association between neurocognition and attenuated psychosis syndrome: Preliminary evidence from a pilot study among treatment-seeking versus healthy adolescents.

Koren D, Scheyer R, Stern Y, Adres M, Reznik N, Apter A, Seidman LJ.

Schizophr Res. 2019 Jan 8. pii: S0920-9964(18)30732-1. doi: 10.1016/j.schres.2018.12.036. [Epub ahead of print]

PMID:
30630704
12.

Between-network Functional Connectivity Is Modified by Age and Cognitive Task Domain.

Varangis E, Razlighi Q, Habeck CG, Fisher Z, Stern Y.

J Cogn Neurosci. 2019 Apr;31(4):607-622. doi: 10.1162/jocn_a_01368. Epub 2019 Jan 3.

PMID:
30605005
13.

Beyond pass-fail: Examining the potential utility of two thresholds in the autism screening process.

Roberts MY, Stern Y, Hampton LH, Grauzer JM, Miller A, Levin A, Kornfeld B, Davis MM, Kaat A, Estabrook R.

Autism Res. 2019 Jan;12(1):112-122. doi: 10.1002/aur.2045. Epub 2018 Dec 17.

PMID:
30556302
14.

Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

Babulal GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, Astell AJ, Babiloni C, Bahar-Fuchs A, Bell J, Bowman GL, Brickman AM, Chételat G, Ciro C, Cohen AD, Dilworth-Anderson P, Dodge HH, Dreux S, Edland S, Esbensen A, Evered L, Ewers M, Fargo KN, Fortea J, Gonzalez H, Gustafson DR, Head E, Hendrix JA, Hofer SM, Johnson LA, Jutten R, Kilborn K, Lanctôt KL, Manly JJ, Martins RN, Mielke MM, Morris MC, Murray ME, Oh ES, Parra MA, Rissman RA, Roe CM, Santos OA, Scarmeas N, Schneider LS, Schupf N, Sikkes S, Snyder HM, Sohrabi HR, Stern Y, Strydom A, Tang Y, Terrera GM, Teunissen C, Melo van Lent D, Weinborn M, Wesselman L, Wilcock DM, Zetterberg H, O'Bryant SE; International Society to Advance Alzheimer's Research and Treatment, Alzheimer's Association.

Alzheimers Dement. 2019 Feb;15(2):292-312. doi: 10.1016/j.jalz.2018.09.009. Epub 2018 Dec 13.

15.

Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.

Schilling LP, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, de Mello Rieder CR, Gauthier S, Palmini A, Rosa-Neto P; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurobiol. 2018 Nov 9. doi: 10.1007/s12035-018-1405-1. [Epub ahead of print]

PMID:
30414086
16.

Residual disability after severe relapse in people with multiple sclerosis treated with disease-modifying therapy.

Achiron A, Sarova-Pinhas I, Magalashvili D, Stern Y, Gal A, Dolev M, Menascu S, Harari G, Gurevich M.

Mult Scler. 2018 Nov 1:1352458518809903. doi: 10.1177/1352458518809903. [Epub ahead of print]

PMID:
30381992
17.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.

Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, Cash DM, Thomas DL, Dick KM, Cardoso J, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Warren JD, Crutch S, Fox NC, Ourselin S, Schott JM, Rohrer JD, Alexander DC; Genetic FTD Initiative (GENFI); Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Nat Commun. 2018 Oct 15;9(1):4273. doi: 10.1038/s41467-018-05892-0.

18.

Misidentification of Dementia in Medicare Claims and Related Costs.

Zhu CW, Ornstein KA, Cosentino S, Gu Y, Andrews H, Stern Y.

J Am Geriatr Soc. 2019 Feb;67(2):269-276. doi: 10.1111/jgs.15638. Epub 2018 Oct 13.

19.

Sleep and subjective cognitive decline in cognitively healthy elderly: Results from two cohorts.

Tsapanou A, Vlachos GS, Cosentino S, Gu Y, Manly JJ, Brickman AM, Schupf N, Zimmerman ME, Yannakoulia M, Kosmidis MH, Dardiotis E, Hadjigeorgiou G, Sakka P, Stern Y, Scarmeas N, Mayeux R.

J Sleep Res. 2018 Sep 25. doi: 10.1111/jsr.12759. [Epub ahead of print]

PMID:
30251362
20.

The Telephone Interview for Cognitive Status.

Stern Y.

Cogn Behav Neurol. 2018 Sep;31(3):160. doi: 10.1097/WNN.0000000000000168. No abstract available.

PMID:
30239469

Supplemental Content

Loading ...
Support Center